{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:07Z","timestamp":1792782787655,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06595-0","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T16:08:43Z","timestamp":1653062923000},"page":"525-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Utilization of sentinel lymph\u00a0node biopsy in the early ovarian cancer surgery"],"prefix":"10.1007","volume":"307","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syem K.","family":"Barakzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda D.","family":"Jooya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"6595_CR1","unstructured":"Uterine neoplasms (2021) NCCN clinical practice guidelines in oncology (NCCN Guidelines). National Comprehensive Cancer Network. Version 2.2021. http:\/\/www.nccn.org (Accessed 12\/15\/2021)."},{"issue":"5","key":"6595_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1470-2045(11)70070-5","volume":"12","author":"M Ballester","year":"2011","unstructured":"Ballester M, Dubernard G, Lecuru F et al (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12(5):469\u2013476","journal-title":"Lancet Oncol"},{"issue":"3","key":"6595_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","volume":"18","author":"EC Rossi","year":"2017","unstructured":"Rossi EC, Kowalski LD, Scalici J et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18(3):384\u2013392","journal-title":"Lancet Oncol"},{"issue":"10","key":"6595_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","volume":"19","author":"M Frumovitz","year":"2018","unstructured":"Frumovitz M, Plante M, Lee PS et al (2018) Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 19(10):1394\u20131403","journal-title":"Lancet Oncol"},{"issue":"2","key":"6595_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jamasurg.2020.5060","volume":"156","author":"MC Cusimano","year":"2021","unstructured":"Cusimano MC, Vicus D, Pulman K et al (2021) Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surg 156(2):157\u2013164","journal-title":"JAMA Surg"},{"issue":"4","key":"6595_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/AOG.0000000000001648","volume":"128","author":"S Cham","year":"2016","unstructured":"Cham S, Chen L, Burke WM et al (2016) Utilization and outcomes of sentinel lymph node biopsy for vulvar cancer. Obstet Gynecol 128(4):754\u2013760","journal-title":"Obstet Gynecol"},{"key":"6595_CR7","unstructured":"Vulvar cancer (Squamous cell carcinoma) (2021) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). National Comprehensive Cancer Network. Version 3.2021. http:\/\/www.nccn.org (Accessed 12\/15\/2021)."},{"issue":"31","key":"6595_CR8","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1200\/JCO.2011.41.2528","volume":"30","author":"CF Levenback","year":"2012","unstructured":"Levenback CF, Ali S, Coleman RL et al (2012) Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 30(31):3786\u20133791","journal-title":"J Clin Oncol"},{"issue":"7","key":"6595_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","volume":"11","author":"MH Oonk","year":"2010","unstructured":"Oonk MH, van Hemel BM, Hollema H et al (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7):646\u2013652","journal-title":"Lancet Oncol"},{"issue":"6","key":"6595_CR10","doi-asserted-by":"publisher","first-page":"594 e591","DOI":"10.1016\/j.ajog.2017.02.021","volume":"216","author":"JD Wright","year":"2017","unstructured":"Wright JD, Cham S, Chen L et al (2017) Utilization of sentinel lymph node biopsy for uterine cancer. Am J Obstet Gynecol. 216(6):594 e591-594 e513","journal-title":"Am J Obstet Gynecol."},{"issue":"13","key":"6595_CR11","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1200\/JCO.2010.32.0432","volume":"29","author":"F Lecuru","year":"2011","unstructured":"Lecuru F, Mathevet P, Querleu D et al (2011) Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 29(13):1686\u20131691","journal-title":"J Clin Oncol"},{"key":"6595_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","volume":"148","author":"P Mathevet","year":"2021","unstructured":"Mathevet P, Lecuru F, Uzan C et al (2021) Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer 148:307\u2013315","journal-title":"Eur J Cancer"},{"key":"6595_CR13","doi-asserted-by":"crossref","unstructured":"Koh WJ, Greer BE, Abu-Rustum NR, et al (2015) Cervical cancer, version 2.2015. J Natl Compr Canc Netw 13(4):395\u2013404 (quiz 404).","DOI":"10.6004\/jnccn.2015.0055"},{"issue":"4","key":"6595_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ijgc-2019-000332","volume":"29","author":"FR Lecuru","year":"2019","unstructured":"Lecuru FR, McCormack M, Hillemanns P et al (2019) SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol Cancer 29(4):829\u2013834","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"6595_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/ijgc-2018-000049","volume":"29","author":"V Lago","year":"2019","unstructured":"Lago V, Bello P, Montero B et al (2019) Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study. Int J Gynecol Cancer 29(2):377\u2013381","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"6595_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/ijgc-2020-001289","volume":"30","author":"V Lago","year":"2020","unstructured":"Lago V, Bello P, Montero B et al (2020) Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial. Int J Gynecol Cancer 30(9):1390\u20131396","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"6595_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ygyno.2021.03.001","volume":"161","author":"V Lago","year":"2021","unstructured":"Lago V, Montero B, Lopez S et al (2021) Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer. Gynecol Oncol 161(2):408\u2013413","journal-title":"Gynecol Oncol"},{"issue":"9","key":"6595_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1136\/ijgc-2019-000732","volume":"29","author":"V Lago","year":"2019","unstructured":"Lago V, Bello P, Marina Martin MT et al (2019) Sentinel lymph node in apparent early ovarian cancer: open technique. Int J Gynecol Cancer 29(9):1449","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"6595_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jmig.2019.09.790","volume":"27","author":"V Lago","year":"2020","unstructured":"Lago V, Bello P, Matute L et al (2020) Sentinel lymph node technique in apparent early ovarian cancer: laparoscopic technique. J Min Invas Gynecol 27(5):1019\u20131020","journal-title":"J Min Invas Gynecol"},{"issue":"9","key":"6595_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/ijgc-2019-000886","volume":"29","author":"G Scambia","year":"2019","unstructured":"Scambia G, Nero C, Uccella S et al (2019) Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY). Int J Gynecol Cancer 29(9):1437\u20131439","journal-title":"Int J Gynecol Cancer"},{"key":"6595_CR21","doi-asserted-by":"crossref","unstructured":"Uccella S, Nero C, Vizza E, et al. (2019) Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY). Am J Obstet Gynecol. 221(4):324 e321\u2013324 e310.","DOI":"10.1016\/j.ajog.2019.05.005"},{"issue":"7","key":"6595_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/ijgc-2019-000606","volume":"29","author":"F Dell'Orto","year":"2019","unstructured":"Dell\u2019Orto F, Laven P, Delle Marchette M, Lambrechts S, Kruitwagen R, Buda A (2019) Feasibility of sentinel lymph node mapping of the ovary: a systematic review. Int J Gynecol Cancer 29(7):1209\u20131215","journal-title":"Int J Gynecol Cancer"},{"key":"6595_CR23","unstructured":"Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). National Comprehensive Cancer Network. Version 1.2021. http:\/\/www.nccn.org (Accessed 12\/15\/2021)."},{"key":"6595_CR24","unstructured":"National Cancer Institute\u2019s The Surveillance, Epidemiology, and End Results (SEER) Program. http:\/\/seer.cancer.gov\/ (Accessed 12\/21\/2021)."},{"issue":"11","key":"6595_CR25","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","volume":"76","author":"C Zippin","year":"1995","unstructured":"Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76(11):2343\u20132350","journal-title":"Cancer"},{"issue":"18","key":"6595_CR26","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1002\/sim.1200","volume":"21","author":"DW Hosmer","year":"2002","unstructured":"Hosmer DW, Hjort NL (2002) Goodness-of-fit processes for logistic regression: simulation results. Stat Med 21(18):2723\u20132738","journal-title":"Stat Med"},{"issue":"28","key":"6595_CR27","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34(28):3661\u20133679","journal-title":"Stat Med"},{"issue":"5","key":"6595_CR28","doi-asserted-by":"publisher","first-page":"484.e1","DOI":"10.1016\/j.ajog.2019.10.010","volume":"222","author":"K Matsuo","year":"2020","unstructured":"Matsuo K, Nusbaum DJ, Machida H, Huang Y, Khetan V, Matsuzaki S, Klar M, Grubbs BH, Roman LD, Wright JD (2020) Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone. Am J Obstet Gynecol 222(5):484.e1-484.e15","journal-title":"Am J Obstet Gynecol"},{"key":"6595_CR29","doi-asserted-by":"crossref","unstructured":"Mandelbaum RS, Ciccone MA, Nusbaum DJ, et al. (2020) Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy. Am J Obstet Gynecol. 223(1):103 e101\u2013103 e113.","DOI":"10.1016\/j.ajog.2019.12.273"},{"issue":"6","key":"6595_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP (2016) Introduction to the analysis of survival data in the presence of competing risks. Circulation 133(6):601\u2013609","journal-title":"Circulation"},{"issue":"7","key":"6595_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/sim.6782","volume":"35","author":"M Pavlou","year":"2016","unstructured":"Pavlou M, Ambler G, Seaman S, De Iorio M, Omar RZ (2016) Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med 35(7):1159\u20131177","journal-title":"Stat Med"},{"issue":"6","key":"6595_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM (2021) STROBE reporting guidelines for observational studies. JAMA Surg 156(6):577\u2013578","journal-title":"JAMA Surg"},{"key":"6595_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/AOG.0000000000004733","volume":"139","author":"K Matsuo","year":"2022","unstructured":"Matsuo K, Klar M, Nusbaum DJ, Hasanov MF, Vallejo A, Ciesielski KM, Muderspach LI, Roman LD, Wright JD (2022) Utilization and outcomes of sentinel lymph node biopsy for early endometrial cancer. Obstet Gynecol 139:809\u2013820","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6595_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ygyno.2021.10.085","volume":"164","author":"K Matsuo","year":"2022","unstructured":"Matsuo K, Klar M, Khetan VU, Violette CJ, Nusbaum DJ, Muderspach LI, Roman LD, Wright JD (2022) Sentinel lymph node biopsy for stage II endometrial cancer: recent utilization and outcome in the United States. Gynecol Oncol 164(1):46\u201352","journal-title":"Gynecol Oncol"},{"key":"6595_CR35","doi-asserted-by":"crossref","unstructured":"Matsuo K, Klar M, Khetan VU, Vallejo A, Violette CJ, Tavakoli A, Nusbaum DJ, Roman LD, Wright JD (2022) Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification. Gynecol Oncol (in press)","DOI":"10.1016\/j.ygyno.2022.02.023"},{"key":"6595_CR36","doi-asserted-by":"crossref","unstructured":"Matsuo K, Klar M, Ciccone MA, Nusbaum DJ, Shimada M, Roman LD, Wright JD (2022) Incorporation of sentinel lymph node biopsy in cervical cancer surgery: recent US trends. Eur J Surg Oncol (in-press)","DOI":"10.1016\/j.ejso.2022.02.018"},{"issue":"3","key":"6595_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ygyno.2022.01.002","volume":"164","author":"LL Brunette","year":"2022","unstructured":"Brunette LL, Khetan VU, Deshpande RR, Nusbaum DJ, Klar M, Roman LD, Wright JD, Matsuo K (2022) Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States. Gynecol Oncol 164(3):651\u2013657","journal-title":"Gynecol Oncol"},{"key":"6595_CR38","doi-asserted-by":"crossref","unstructured":"Bainvoll L, Brunette LL, Muderspach LI, Khetan VU, Roman LD, Klar M, Matsuo K (2021) Sentinel lymph node biopsy for vulvar melanoma: trends in tumor stage-specific utilization. Am J Obstet Gynecol. (in-press)","DOI":"10.1016\/j.ajog.2021.10.032"},{"key":"6595_CR39","unstructured":"ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: a feasibility study. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04051502 (Accessed 12\/22\/2021)."},{"key":"6595_CR40","unstructured":"Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04714931. (Accessed 12\/22\/2021)."},{"key":"6595_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/ijgc-2019-001110","volume":"30","author":"LC Turco","year":"2020","unstructured":"Turco LC, Vargiu V, Nero C, Fagotti A, Scambia G, Cosentino F (2020) Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye. Int J Gynecol Cancer 30:712\u2013713","journal-title":"Int J Gynecol Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06595-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T09:35:25Z","timestamp":1680687325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06595-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["6595"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06595-0","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"all were unrelated to this work: consultant, research grant, Merck, and royalties, UpToDate (J.D.W.); consultant, Quantgene (L.D.R.); none for others.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"University of Southern California Institutional Review Board exemption (HS-16-00481).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The manuscript\u2019s corresponding author (K.M.) affirms that the manuscript is\u200b a honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The National Cancer Institute's Surveillance, Epidemiology, and End Results Program is the source of the de-identified data used; and the program has not verified and is not responsible for the statistical validity of the data analysis or the conclusions \u200bderived by the study team. Race\/ethnicity was grouped per the program definition.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency"}}]}}